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Abstract
Background: The relation of placental gross morphology and the outcome
of pregnancies complicated with diabetes mellitus in comparison with healthy
pregnancies is not known. Identifying significant differences in pregnancy outcomes
in Gestational Diabetes Mellitus (GDM) and healthy pregnancies by the means of
morphologic measurements can induce the use of antenatal ultrasonography of
placental parameters to predict pregnancy outcomes.
Objective: This study aimed to evaluate the relationship between placental
morphological parameters of the placenta and cord and the outcomes of pregnancies
complicated with diabetes mellitus.
Materials and Methods: In this case-control study, which was conducted at two referral
perinatology center in Tehran between March 2017 and November 2018, 60 pregnant
women with GDM who were controlled with either diet or insulin as the case group
and 60 pregnant women without GDM as the control group were enrolled. The study
population were selected from patients who had their prenatal care and delivery in
Mahdieh and Shohadaye Tajrish Hospital. The data was collected by taking sickness
history, using data from patients files, and measuring of placental and newborn
parameters after delivery. GDM was diagnosed either by 75 gr or 100 gr oral glucose
tolerance tests. Placenta parameters, umbilical cord features, and newborn outcomes
were compared between the two groups.
Results: Placental weight, diameter, number of lobes, thickness, placental weight to-
newborn weight ratio, place of umbilical cord insertion, length, coiling, and diameter of
the umbilical cord are similar in two groups. Newborn weight, NICU admission, ABG,
and Apgar score are also the same in well-controlled GDM pregnancy and pregnancy
without GDM.
Conclusion:Good controlled GDM causes no difference in placental grossmorphology
and pregnancy outcome compared to a healthy pregnancy.
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1. Introduction
Gestational diabetes mellitus (GDM) is one of
the most common complications in pregnancy.
It has been estimated that 7% of pregnancies
in the US are complicated with diabetes melitus
(DM) (1). GDM is a known risk factor for pregnancy
complications such as macrosomia, shoulder
dystocia, birth trauma, increased rate of cesarean
delivery, and neonatal metabolic disorders. Long-
term health side effects among children born to
mother who has GDM include obesity, impairment
of glucose tolerance. Women with history of
GDM more often have subsequent diabetes
(2). Development of placenta in diabetes has
structural and functional differences. It depends on
a glycemic control during placental development,
type of treatment, and period of time when
diabetes was not controlled (3). The placenta is a
morpho-functional structure with a main metabolic
role during pregnancy. It is the crucial organ
responsible for nutrient uptake, waste elimination,
and gas exchange between fetus and mother
(4). During pregnancy associated with diabetes,
the placenta undergoes some functional and
structural pathologic changes, such as increased
placental weight and placental lesions (5). Due
to the growth-promoting and growth-restricting
factors, DM complicates pregnancy and alters
normal growth patterns of fetus and placenta
(6).
Considering the possibility of the relation
between the placenta morphology, umbilical
cord, and newborn parameters with diabetes,
this study was aimed to evaluate the relationship
between placental morphological parameters
such as weight, diameter, number of lobes,
thickness, umbilical cord insertion, length,
coiling and diameter of the umbilical cord with
the outcome of pregnancies complicated with
DM.
2. Materials and Methods
In this case-control study, 60 pregnant
women with GDM who were controlled with
either diet or insulin as the case group, and 60
pregnant women without GDM as the control
group were enrolled. The control group were
selected from pregnant women, referred to
Mahdieh Hospital and Shohadaye Tajrish Hospital,
Tehran, Iran between March 2017 and November
2018.
Our inclusion criteria for selecting the case
group were gestational age ≥ 37 weeks at
delivery and diagnosed gestational diabetes
mellitus.
All women with delivery at < 37 weeks,
pregnant women with other maternal medical
diseases (PIH, chronic hypertension, DM
type I and II started before pregnancy, other
systemic diseases), multiple pregnancy,
tumors of placenta (angioma etc.), two vessels
umbilical cord were excluded from the
study.
GDM was diagnosed either by 75 gr or by 100 gr
oral glucose tolerance test.
Placenta parameters, umbilical cord features,
and newborn outcomes were compared between
the two groups.
The aim of glycemic control was HbA1C <
%6, without significant hypoglycemia, Fasting
blood sugar < 95 mg/dL and either, 1-hr
postprandial < 140 mg/dL or 2-hr postprandial
< 120 mg/dL according to American diabetes
association (7). The control group had
normal response to oral glucose tolerance
test.
Data including maternal parameters (age, Body
mass index (BMI), gestational age, parity, gravity),
placental morphological parameters (after they
were tagged and washed thoroughly to remove
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blood and mucus) such as weight, diameter from
the widest part, number of lobes, thickness (that
was taken from cord insertion area), umbilical
cord insertion, length from placental end to the
fetal end, coiling, diameter of umbilical cord in
transverse cut, and newborn parameters (NICU
admission, weight of newborn, ABG, Apgar score,
presence of meconium in amniotic fluid) were
collected.
Umbilical cord was considered vellamentous
if it was inserted in the membranes before
reaching the chorionic plate. Umbilical cord was
considered marginal when ≤ 1 cm is left to
placental margin, central when cord insertion place
was ≤ 1 cm away from center, other types of
cord insertion we named paracentral. The coiling
index is the amount of coils divided by length of
umbilical cord in cm. Coiling index was considered
hypocoiled if it was below 0.1 coils/cm and was
considered hypercoiled if it was above 0.3 coils/cm
(8).
2.1. Ethical consideration
Signed written informed consent forms were
collected from the volunteers participating in
the study. The ethics committee of Shahid
Beheshti University of Medical Sciences,
Tehran, Iran approved the study in order
not to undermine the patient’s rights (Code:
IR.SBMU.MSP.REC.1396.476).
2.2. Statistical analysis
Data were entered into SPSS-21 software.
Data was assessed with Kolmogorov-Smimov
test at first. Thereafter, data were analyzed
using Chi-square and paired sample t tests. To
examine the correlation between the variables,
Pearson and Spearman correlation methods were
used. Also confidence interval was 95% and the
statistical significance was considered as p <
0.05.
3. Results
A total of 120 pregnant women participated
in this case-control study (n = 60/each). All
of the participants delivered live newborn at
gestational age> 37wk. Participants’ demographic
characteristics were showed in table I. The mean
age of women in the case group was 30 ± 6.2 yr,
while the mean age of those in the control group
was 27.7 ± 6.2 yr. BMI, age, parity, and gravity in
the case and control group didn’t have significant
differences (Table I).
Thirty-eight women in the case group and
twenty-two women in the control group underwent
cesarean delivery, the difference between the two
groups was significant (p = 0.03).
Blood sugar in all mothers with GDM were well
controlled; 55 women were controlled only by diet
and 5 mothers consumed insulin.
The placental and umbilical cord gross
morphology including placental weight, diameter,
number of lobes, thickness, place of umbilical
cord insertion, cord length, coiling, the diameter of
umbilical cord, and placental weight-to-newborn
weight ratio had no significant differences between
the two groups (Table II).
The mean newborn weight in case group was
3380.8 ± 404.1 gr and in control group 3320 ±
432.1 gr (p = 0.427, with no significant differences).
All newborn in case and control groups had Apgar
score of 10 at the 5th min and normal ABG
parameters. About 10% of the newborns in the
case group and 8.3% newborns in the control
group were hospitalized to NICU (p = 0.67). Four
newborns (6.7%) in the control group and none
in the case group had meconium excretion in
amniotic fluid (p = 0.042, significant).
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Table I. Demographic characteristics of study participants in two groups
Control group Case group P-value
Mean age (yr)* 27.7 ± 6.2 30 ± 6.2 0.331
Type of delivery**
Cesarean 22 (36.7) 38 (63.3)
NVD 38 (63.3) 22 (36.7)
0.003
BMI**
< 25 28 (46.7) 20 (33.3)
25-29 24 (44.0) 29 (48.3)
> 30 8 (13.3) 11 (18.3)
0.32
Gravity**
1 19 (31.7) 22 (36.7)
> 1 41 (68.3) 38 (63.3)
0.56
Parity**
1 23 (38.3) 31 (51.7)
> 1 38 (61.7) 29 (48.3)
0.14
Gestational age**
37-37 + 6 6 (10.0) 9 (15.0)
38-38 + 6 24 (40.0) 23 (38.3)
39-39 + 6 15 (25.0) 15 (25.0)
> 40 15 (25.0) 13 (21.7)
0.86
Type of diabetes control**
Under diet 0 55 (91.7)
Under insulin 0 5 (8.3)
Without diet 60 (100) 0
< 0.001
* Data presented as Mean ± SD; ** Data presented as n (%); Chi-square test
NVD: Normal vaginal delivery; BMI: Body mass index
Table II. Parameters of placental and umbilical cord gross morphology in cases with GDM and control without GDM
Control group Case group P-value
Placental weight∗
< 400 2 (3.3) 0 (0.0)
400-600 28 (46.7) 27 (45.0)
600-800 22 (36.7) 30 (50.0)
800-1000 8 (13.3) 3 (5.0)
0.37𝑎
Place of umbilical cord insertion*
Central 12 (20.0) 18 (30.0)
Paracentral 41 (68.3) 30 (50.0)
Marginal 5 (8.3) 12 (20.0)
Velamentous 2 (3.3) 0 (0.0)
0.037𝑎
Number of placental lobes*
One lobe 52 (86.7) 56 (93.3)
More than one lobe 8 (13.3) 4 (6.7)
0.22𝑎
Placental shape*
Round 28 (46.7) 25 (41.7)
Oval 32 (53.3) 34 (56.7)
Irregular 0 (0.0) 1 (1.7)
0.54𝑎
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Table II. Continued
Control group Case group P-value
Coiling*
Hypocoiled 12 (20) 9 (15.0)
Normocoiled 48 (80) 51 (85.0)
0.86𝑎
Direction of coiling*
Left 50 (83.3) 50 (83.3)
Right 10 (16.8) 10 (16.7)
1𝑎
Diameter of umbilical cord*
2-Jan 35 (58.3) 32 (53.3)
> 2 25 (41.7) 28 (46.7)
0.58𝑎
Central thickness of placenta*
< 2 20 (33.3) 18 (30.0)
4-Feb 40 (66.7) 42 (70.0)
0.695𝑎
Diameter of placenta*
< 16 15 (25) 15 (25.0)
16-18.9 20 (33.3) 18 (30.0)
19-22 21 (35) 24 (40)
> 22 4 (6.7) 3 (5.0)
0.93𝑎
Newborn weight (gr)** 3320 ± 432.1 3380.8 ± 404.1 0.50𝑏
Umbilical length (cm)** 52.2 ± 9.7 50.95 ± 10.2 0.75𝑏
Placental weight to newborn*
< 1:6 42 (70) 45 (75.0)
1:6-1:7 14 (23.3) 12 (20.0)
> 1:7 4 (6.7) weight ratio 3 (5.0)
0.819𝑎
* Data presented as Mean±SD. ** Data presented as n (%).𝑎Chi-square, 𝑏t test
4. Discussion
This investigation assessed the differences
between placental gross morphology and
pregnancy outcome in GDM and healthy
pregnancy. The study suggests that there
is no difference in the aforementioned
parameters between a healthy pregnancy
and a good controlled GDM pregnancy.
Good controlled GDM group and healthy
pregnancy had almost same parameters of
placental gross morphology and pregnancy
outcome. This shows the effect of well GDM
treatment.
So, ultrasound investigation of the placenta
and umbilical cord antepartum in pregnancy
with well-controlled GDM will not help to predict
bad pregnancy outcome in these patients.
In our research four newborns in the control
group had meconium in amniotic fluid but none
in the case group had meconium excreted
in the amniotic fluid. These results might
be due to immaturity of the gastrointestinal
tract in newborns of mothers with GDM. But
further evaluation is required because all
four cases in the control group were born by
normal vaginal delivery, and more cesarean
section was performed in the GDM group;
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this can cause differences because in elective
cesarean section we rarely see meconium
in amniotic fluid compared to normal vaginal
delivery.
It is found that umbilical coiling index (UCI) can
be a marker of adverse pregnancy outcomes,
for example; hypocoiling (< 0.12) is associated
with placental abruption, decreased amniotic
fluid, preeclampsia, abnormal fetal heart
rate.
Hypercoiling (> 0.36) has relation with
increased amniotic fluid, congenital disorders,
delivery by cesarean section, and respiratory
distress of the newborn (9). This finding is in
some ways consistent with a study conducted in
2019 which concluded that GDM is connected
to increase of hospital admission, congenital
abnormalities, emergent delivery by cesarean
section, PROM, preterm birth. Increase in
the UCI is connected to macrosomia and
meconium-stained amniotic fluid in patients
with GDM (10). Further, in some investigations,
the evaluations showed that antenatal UCI
that was performed by ultrasound at 18-23 wk
of gestation could predict postnatal UCI with
strong diagnostic accuracy in GDM group (11,
12).
In a study assessing the possible adverse
effects of uncontrolled DM on morphometric
of the umbilical cord and its vessels, the
investigation showed that single umbilical artery
(SUA) wasmuchmore frequently seen inmothers
with gestational diabetes compared to normal
pregnancy. It was shown that lean cord and SUA
were connected to GDM and has association
with unfavorable fetal outcome (13). Our study
shows that proper glycemic control hasmanaged
these adverse effects in our patients with
GDM.
It was shown in another investigation that
the circumference and the mean diameter of
umbilical cord is larger in GDM mothers than
non-diabetics (p = 0.0001). But difference
in type of insertion, coiling index, false
knots, and length of umbilical cord were
insignificant betweenGDMand healthy pregnant
women.
Also, the number of umbilical cord vessels in
both groups was the same and true knots were
absent (14).
Contrary to the results of our study in the study
by Rabia Arshad and coworkers the group of
GDM on diet had heavier placenta compared
to the control’s. They also demonstrated that
villous immaturity, chorangiosis, infarction, and
syncytial knots in light microscopy were present
in the GDM group versus the control group
(15).
Limitation
The limitations to this study are that all
patients of case group had well-controlled
GDM, so, we suggest studying poor controlled
GDM next time and comparing it with healthy
pregnancies. Most women in GDM group
had elective cesarean sections, but in control
group the mothers delivered through normal
vaginal delivery NVD. Although it can’t change
placental morphological parameters, it may
influence the pregnancy outcome. Most
women in this study controlled their GDM
by diet, it is recommended to study mothers
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controlling GDM with insulin and compare the
results.
5. Conclusion
This study identifies that good controlled
GDM at pregnancy makes the outcome of the
pregnancy and gross structure of placenta equal
to healthy pregnancies without GDM. It shows
the significant role of prenatal care and early
GDM diagnosis and treatment in newborns’
health.
Acknowledgments
This article has been extracted from the
thesis written by Mrs Nazemi at the School of
Medicine, this article was financially supported
by Shahid Beheshti University of Medical
Sciences (Registration No: 203).
Conflict of Interest
There is no conflict of interest to be declared.
References
[1] Albrecht SS, Kuklina EV, Bansil P, Jamieson DJ,
Whiteman MK, Kourtis AP, et al. Diabetes trends
among delivery hospitalizations in the US, 1994-
2004. Diabetes Care 2010; 33: 768–773.
[2] Gagnon AJ, McDermott S, Rigol−Chachamovich
J, Bandyopadhyay M, Stray−Pedersen B, Stewart
D, et al. International migration and gestational
diabetes mellitus: a systematic review of the
literature and meta−analysis. Paediatr Perinat
Epidemiol 2011; 25: 575–592.
[3] Desoye G, Hauguel-de Mouzon S. The human
placenta in gestational diabetes mellitus: the insulin
and cytokine network. Diabetes care. 2007 Jul
1;30(Supplement 2):S120–6.
[4] Berceanu C, Tetileanu AV, Ofiţeru AM, Brătilă E,
Mehedinţu C, Voicu NL, et al. Morphological and
ultrasound findings in the placenta of diabetic
pregnancy. Rom J Morphol Embryol 2018; 59: 175–
186.
[5] Huynh J, Dawson D, Roberts D, Bentley-Lewis R. A
systematic review of placental pathology in maternal
diabetes mellitus. Placenta 2015; 36: 101–114.
[6] Hiden U, Desoye G. The placenta in a diabetic
pregnancy. J Reproduktionsmed Endokrinol 2010; 7:
27–33.
[7] American Diabetes Association. Management of
diabetes in pregnancy: Standards of medical care
in diabetes-2019. Diabetes Care 2019; 42 (Suppl.):
S165–S172.
[8] Strong Jr TH, Jarles DL, Vega JS, Feldman DB.
The umbilical coiling index. American journal of
obstetrics and gynecology 1994; 170: 29–32.
[9] Chitra T, Sushanth YS, Raghavan S. Umbilical coiling
index as a marker of perinatal outcome: an analytical
study. Obstet Gynecol Int 2012; 2012: 13689.
[10] Najafi L, Abedini A, Kadivar M, Khajavi A, Bordbar
A, Noohi AH, et al. Gestational diabetes mellitus:
the correlation between umbilical coiling index,
and intrapartum as well as neonatal outcomes. J
Diabetes Metab Disord 2019; 18: 51–57.
[11] Najafi L, Malek M, Abedini A, Kadivar M, Ebrahim
Valojerdi A, Zahmatkesh E, et al. Prediction of
postnatal abnormal coiling of the umbilical cord in
gestational diabetes mellitus: a diagnostic accuracy
study. J Matern Fetal Neonatal Med 2020; 33: 1107–
1113.
[12] Najafi L, Khamseh ME, Kashanian M, Younesi L,
Abedini A, Valojerdi AE, et al. Antenatal umbilical
coiling index in gestational diabetes mellitus and
non-gestational diabetes pregnancy. Taiwan J
Obstet Gynecol 2018; 57: 487–492.
[13] Lateef RH. Adverse effects of gestational diabetes
mellitus (GDM) on measurements of the umbilical
cord and its vessels. Pak J Biol Sci 2015; 18: 346–
351.
[14] Ennazhiyil SV, Ramakrishnan PK, Akshara VR,
Premlal KS, Chitra S, Benjamin W, et al. Effects
of gestational diabetes mellitus on umbilical cord
https://doi.org/10.18502/ijrm.v13i6.7282 Page 413
International Journal of Reproductive BioMedicine Pooransari et al.
morphology: A comparative study. Journal of Clinical
and Diagnostic Research 2019; 13: AC06–AC09.
[15] Arshad R, Kanpurwala MA, Karim N, Hassan
JA. Effects of diet and metformin on placental
morphology in gestational diabetes mellitus. Pak J
Med Sci 2016; 32: 1522–1527.
Page 414 https://doi.org/10.18502/ijrm.v13i6.7282
